794
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Spatiotemporal Variations in Chronic Obstructive Pulmonary Disease Mortality in China: Multilevel Evidence from 2006 to 2012

, , , , , , , , , & show all

References

  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095–2128.
  • Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 2013; 381(9882):1987–2015.
  • Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, et al. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest 2010; 138(1):20–31.
  • Schikowski T, Mills IC, Anderson HR, Cohen A, Hansell A, Kauffmann F, et al. Ambient air pollution: a cause of COPD? Eur Respir J 2014; 43(1):250–263.
  • Lam KB, Yin P, Jiang CQ, Zhang WS, Adab P, Miller MR, et al. Past dust and GAS/FUME exposure and COPD in Chinese: the Guangzhou Biobank Cohort Study. Respir Med 2012; 106(10):1421–1428.
  • Yang L, Zhou M, Smith M, Yang G, Peto R, Wang J, et al. Body mass index and chronic obstructive pulmonary disease-related mortality: a nationally representative prospective study of 220,000 men in China. Int J Epidemiol 2010; 39(4):1027–1036.
  • Yin P, Zhang M, Li Y, Jiang Y, Zhao W. Prevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007. BMC Public Health 2011; 11:586.
  • Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the challenges to health equity in China. Lancet 2008; 372(9648):1493–1501.
  • Yang G, Hu J, Rao KQ, Ma J, Rao C, Lopez AD. Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr 2005; 3(1):3.
  • Zhou MG JY, Huang ZJ, Wu F Adjustment and representativeness evaluation of national disease surveillance points system. Ji Bing Jian Ce 2010; 25(3): 239–244.
  • Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, et al. Mortality attributable to smoking in China. N Engl J Med 2009; 360(2):150–159.
  • Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Commun Health 2011; 65(1):26–34.
  • Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310(9):948–959.
  • Li Y, Wang L, Jiang Y, Zhang M, Wang L. Risk factors for noncommunicable chronic diseases in women in China: surveillance efforts. Bull World Health Organ 2013; 91(9):650–660.
  • Rasbash J BW, Goldstein H, Yang M, Plewis I, Healy M, et al. A user's guide to MLwiN. London, UK: Institute of Education, 2000.
  • Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Commun Health 2006; 60(4):290–297.
  • Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med 2007; 4(5):e112.
  • Ezzati M, Friedman AB, Kulkarni SC, Murray CJ. The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med 2008; 5(4):e66.
  • Pearce J, Tisch C, Barnett R. Have geographical inequalities in cause-specific mortality in New Zealand increased during the period 1980–2001? N Z Med J 2008; 121(1281):15–27.
  • Erbas B, Ullah S, Hyndman RJ, Scollo M, Abramson M. Forecasts of COPD mortality in Australia: 2006-2025. BMC Med Res Methodol 2012; 12:17.
  • Ford ES, Mannino DM, Zhao G, Li C, Croft JB. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971–1975 and 1988–1994. Chest 2012; 141(1):101–110.
  • Lopez-Campos JL, Ruiz-Ramos M, Soriano JB. COPD mortality rates in Andalusia, Spain, 1975-2010: a joinpoint regression analysis. Int J Tuberc Lung Dis 2013; 17(1):131–136.
  • Lopez-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir Med 2014; 2(1):54–62.
  • Pham TM, Ozasa K, Kubo T, Fujino Y, Sakata R, Grant EJ, et al. Age-period-cohort analysis of chronic obstructive pulmonary disease mortality in Japan, 1950–2004. J Epidemiol 2012; 22(4):302–307.
  • Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. N Engl J Med 2011; 364(25):2469–2470.
  • Zhang J, Mauzerall DL, Zhu T, Liang S, Ezzati M, Remais JV. Environmental health in China: progress towards clean air and safe water. Lancet 2010; 375(9720):1110–1119.
  • Lewis DR, Clegg LX, Johnson NJ. Lung disease mortality in the United States: the National Longitudinal Mortality Study. Int J Tuberc Lung Dis 2009; 13(8):1008–1014.
  • Prescott E, Godtfredsen N, Vestbo J, Osler M. Social position and mortality from respiratory diseases in males and females. Eur Respir J 2003; 21(5):821–826.
  • Zhou M, Offer A, Yang G, Smith M, Hui G, Whitlock G, et al. Body mass index, blood pressure, and mortality from stroke: a nationally representative prospective study of 212,000 Chinese men. Stroke 2008; 39(3):753–759.
  • Leyland AH, Goldstein H. Multilevel Modelling of Health Statistics. New York: Wiley; 2001.
  • Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380(9836):37–43.
  • Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J 2006; 28(4):781–785.
  • Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med 2013; 187(7):721–727.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.